Menu Search
Equities

Cell Impact AB (publ)

ICLA:MUN

Cell Impact AB (publ)

Actions
  • Price (EUR)0.0153
  • Today's Change-0.001 / -8.38%
  • Shares traded18.00k
  • 1 Year change-29.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Cell Impact AB (publ)'s revenues fell -38.47% from 76.81m to 47.26m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 104.21m to a larger loss of 121.40m.
Gross margin-43.73%
Net profit margin-277.37%
Operating margin-273.03%
Return on assets-31.88%
Return on equity-40.02%
Return on investment-35.88%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at Cell Impact AB (publ) fell by 64.78m. Cash Flow from Financing totalled 88.09m or 186.39% of revenues. In addition the company used 100.97m for operations while cash used for investing totalled 51.78m.
Cash flow per share-0.1198
Price/Cash flow per share--
Book value per share0.4359
Tangible book value per share0.422
More ▼

Balance sheet in SEKView more

Cell Impact AB (publ) appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.76% of the market capitalization can be attributed to its 99.89m and debt could be paid in full if management chose.
Current ratio3.83
Quick ratio2.06
Total debt/total equity0.1442
Total debt/total capital0.126
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.